Publications by authors named "David Claxton"

Claim this Profile
A
Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia via a cytotoxic integrated stress response.
Johnson Ung, Su-Fern Tan, Jeremy J P Shaw, Maansi Taori, Tess M Deddens, David F Claxton

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.
John M Pagel, Megan Othus, Guillermo Garcia-Manero, Min Fang, Jerald P Radich, David Claxton

JCO Oncol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HoxBlinc lncRNA reprograms CTCF-independent TADs to drive leukemic transcription and HSC dysregulation in NUP98-rearranged leukemia.
Karina Hamamoto, Ganqian Zhu, Qian Lai, Julia Lesperance, Huacheng Luo, David Claxton

J Clin Invest· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed Chimerism.
Ruoheng Zhang, Yimeng Shang, Joseph Cioccio, Kevin Rakszawski, Myles Nickolich, David Claxton

J Mol Diagn· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.
Jeffrey J Pu, Kristin N Berger, Chunlei Zheng, Nhan Do, David F Claxton

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02.
Akshita Khosla, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, David Claxton

Blood Transfus· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol.
Neil D Palmisiano, Ju-Whei Lee, David F Claxton, Elisabeth M Paietta, Hassan Alkhateeb

EJHaem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Deworming to Cancer Therapy: Benzimidazoles in Hematological Malignancies.
Upendarrao Golla, Satyam Patel, Nyah Shah, Stella Talamo, Riya Bhalodia, David Claxton

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation.
Emma Zulch, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, David Claxton

Leuk Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods.
Darren Brow, Hiroko Shike, Jasmine Kendrick, Linnea Pettersson, Shin Mineishi, David F Claxton

Hum Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma.
Emma G Guare, Cory M Hale, Jeffrey Sivik, Erik Lehman, Yoshika Inoue, David Claxton

Transpl Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation: Comparison of Two Chimerism Test Strategies, Next-Generation Sequencing versus a Combination of Short-Tandem Repeats and Quantitative PCR.
Aiwen Zhang, Stacey Macecevic, Dawn Thomas, Jeffrey Allen, Sarah Mandley, David Claxton

J Mol Diagn· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes.
B Bishal Paudel, Su-Fern Tan, Todd E Fox, Johnson Ung, Upendarrao Golla, David Claxton

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
Guillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, John M Pagel, Jerald P Radich, David Claxton

Leukemia· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia.
Seema Naik, Kevin Rakszawski, Hong Zheng, David Claxton, Kentaro Minagawa

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia.
Johnson Ung, Su-Fern Tan, Todd E Fox, Jeremy J P Shaw, Maansi Taori, David F Claxton

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model.
Bei Jia, Chenchen Zhao, Kentaro Minagawa, Hiroko Shike, David F Claxton

J Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia.
Johnson Ung, Su-Fern Tan, Todd E Fox, Jeremy Jp Shaw, Maansi Taori, David F Claxton

bioRxiv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells.
Fenghua Qian, Shaneice K Nettleford, Jiayan Zhou, Brooke E Arner, Molly A Hall, David F Claxton

Cell Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
Brynn Levy, Linda B Baughn, Yassmine Akkari, Scott Chartrand, Brandon LaBarge, David Claxton

Blood Adv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes.
B Bishal Paudel, Su-Fern Tan, Todd E Fox, Johnson Ung, Jeremy Shaw, David Claxton

bioRxiv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis.
Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Seema Naik, David Claxton

Ann Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia.
Kelsey H Fisher-Wellman, Miki Kassai, James T Hagen, P Darrell Neufer, Mark Kester, David F Claxton

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients.
Melanie Potiaumpai, Kathryn H Schmitz, Shin Mineishi, Seema Naik, Baldeep Wirk, David Claxton

BMJ Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide.
Neal Shah, Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, David Claxton

Leuk Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis